AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

AI-Assisted Analysis of Range of Motion in Patients With Low Back Pain

Recruitingn/aAges 18 Years - 65 YearsAllPamukkale University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Low back pain (LBP) is a common musculoskeletal problem that is frequently encountered in the population and can occur at any age. Responsible for the loss of a full healthy year in both the 10-24 and 50-74 age groups, LBP causes significant personal and social losses and increases healthcare costs. In the classification of low back pain, pain that persists for up to 6 weeks is defined as acute, pain that lasts between 6-12 weeks is subacute, and pain that persists for more than 12 weeks is considered chronic low back pain (CLBP). Chronic LBP (CLBP) leads to fear of movement, causing patients to limit their daily activities and social participation to avoid pain. A sedentary lifestyle in LBP patients is a factor that contributes to the chronicity of the disease. While most acute LBP patients recover well within a few weeks or months, the prognosis for patients with chronic low back pai

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Ages 18-65 * Individuals who have experienced lower back pain for at least 3 months * Individuals who have consulted a doctor at least once due to lower back pain * Individuals who agree to participate in the study and have signed the informed consent form Exclusion Criteria: * Individuals who have undergone surgical intervention due to lower back pain * Individuals with acute traumatic injuries * Individuals with neurological or systemic diseases unrelated to the musculoskeletal system * Individuals who have received physiotherapy or surgical treatment for lower back pain in the last three months * Pregnancy
๐Ÿ’Š

What it tests

  • Assessment of Joint Range of Motion
๐Ÿ“

Where

1 site
Pamukkale University
Denizli, Turkey (Tรผrkiye)
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy